astrazeneca glp 1 Expands into Obesity with Oral GLP-1 Therapy | Ahmad Hammoud, Pharmacist, One Health Professional posted on the topic GLP-1R Agonists - Glucagon-Like Peptide

Rhonda Patrick: I think the take home there is a lot of people with a darker skin living in sub-Saharan Africa or people living in India with darker skin or in the Philippines, these equatorial regions where there's, you tend to see darker skin because it's protection from the burning rays of the sun

Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis

Impact on Food Industry Sectors The use of GLP-1 medication is well documented, and regardless of the perceived pros and cons of usage, the fact remains that adoption is rapidly growing, and that GLP-1 users consume 1540% fewer calories and report reduced cravings for sweet, salty, fatty, and alcoholic foods

EMBO J 24 : 32663278

Illouz F, Braun D, Briet C, Schweizer U, Rodien P